Hyphens Pharma licenses Wynzora® Cream for ASEAN countries from MC2 TherapeuticsMarch 18, 2024Biotheus Expanded Their Partnership with Hansoh Pharma for Developing EGFR/cMET Bispecific Antibody-Drug ConjugatesMarch 18, 2024Biotech trade association to split with China’s WuXi AppTecMarch 18, 2024Capital Markets & FinancingMoreBiotech trade association to split with China’s WuXi AppTecMarch 18, 2024ASLAN Pharmaceuticals Announces $5 Million Registered Direct OfferingMarch 17, 2024Business DevelopmentMoreHyphens Pharma licenses Wynzora® Cream for ASEAN countries from MC2 TherapeuticsMarch 18, 2024Clinical & RegulatoryMoreBeiGene Receives FDA Approval for TEVIMBRA® for the Treatment of Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Prior ChemotherapyMarch 18, 2024Innovent Announces Primary Endpoint Met in the Phase 3 Clinical Trial (RESTORE-1) of IBI311 (Anti-IGF-1R Antibody) in Treating Thyroid Eye Disease and Plans to Submit NDA to the NMPA February 26, 2024PublicationsMoreRejuvenate Bio shows epigenetic reprogramming extends lifespan in normal miceFebruary 26, 2024PeopleMoreYS Biopharma Announces Appointment of New DirectorsFebruary 19, 2024Cantor Fitzgerald Bolsters Healthcare and Biotechnology Equity Research Team with Addition of Josh Schimmer, M.D., and Eric Schmidt, Ph.D.September 10, 2023AwardsMorePharming shortlisted for prestigious Scrip awards 2023September 24, 2023PresentationsMoreAdagene to Present at Investor and Scientific Conferences in SeptemberSeptember 9, 2023Gracell Biotechnologies to Present Updated Clinical Data on BCMA/CD19 Dual-Targeting FasTCAR-T GC012F in Newly Diagnosed Multiple Myeloma at the 2023 International Myeloma Society Annual MeetingSeptember 9, 2023Financial ResultsMoreLianBio Announces Completion of Strategic ReviewFebruary 18, 2024Aesthetic Medical International Reports First Half of 2023 Unaudited Financial ResultsSeptember 9, 2023
